Assessment of attenuation of varicella‐zoster virus vaccines based on genomic comparison
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.28590 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Jae Yun Moon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Science and Technology, Ajou University, Suwon, South Korea. Hauptthemen laut MEDLINE: Chickenpox, Herpes Zoster, Herpes Zoster Vaccine. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Live attenuated varicella‐zoster virus (VZV) vaccines are used to prevent chickenpox and shingles. Single nucleotide polymorphisms (SNPs) that occur during the attenuation of parental strains are critical indicators of vaccine safety. To assess the attenuation of commercial VZV vaccines, genetic variants were comprehensively examined through high‐throughput sequencing of viral DNA isolated from four VZV vaccines (Barycela, VarilRix, VariVax, and SKY Varicella). Whole‐genome comparison of the four vaccines with the wild‐type strain (Dumas) revealed that the sequences are highly conserved on a genome‐wide scale. Among the 196 common variants across the four vaccines, 195 were already present in the genome of the parental strain (pOka), indicating that the variants occurred during the generation of the parental strain from the Dumas strain. Compared to the pOka genome, the vaccines exhibited distinct variant frequencies on a genome‐wide and within an attenuation‐related open reading frame. In particular, attenuation‐associated 42 SNPs showed that Barycela, VarilRix, VariVax, and SKY Varicella are in ascending order regarding similarity with pOka‐like genotypes, which in turn, might provide genomic evidence for the levels of attenuation. Finally, the phylogenetic network analysis demonstrated that genetic distances from the parental strain correlated with the attenuation levels of the vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Science and Technology, Ajou University, Suwon, South Korea.
- Division of R&D Corporate Development, GC Biopharma, Yongin, South Korea.
- Department of Biological Sciences, Ajou University, Suwon, South Korea.
ORCID-Profile: Daechan Park
Förderung
- National Research Foundation of Korea
Zitieren
APA
Moon, J. Y., Seo, J., Lee, J., & Park, D. (2023). Assessment of attenuation of varicella‐zoster virus vaccines based on genomic comparison. Journal of Medical Virology. https://doi.org/10.1002/jmv.28590
Vancouver
Moon JY, Seo J, Lee J, Park D. Assessment of attenuation of varicella‐zoster virus vaccines based on genomic comparison. Journal of Medical Virology. 2023. doi:10.1002/jmv.28590
BibTeX
@article{Moon2023,
author = {Moon, Jae Yun and Seo, Jina and Lee, Jaewoo and Park, Daechan},
title = {Assessment of attenuation of varicella‐zoster virus vaccines based on genomic comparison},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.28590}
}
EUVIMED